Probabilistic Modeling of Rosette Formation  by Long, Mian et al.
Probabilistic Modeling of Rosette Formation
Mian Long,* Juan Chen,* Ning Jiang,y Periasamy Selvaraj,z Rodger P. McEver,§{ and Cheng Zhuy
*National Microgravity Laboratory, Institute of Mechanics, Chinese Academy of Sciences, Beijing 100080, People’s Republic of China;
yCoulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332; zDepartment of Pathology and
Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322; and §Cardiovascular Biology Research Program,
Oklahoma Medical Research Foundation, and {Department of Biochemistry and Molecular Biology and Oklahoma Center for Medical
Glycobiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104
ABSTRACT Rosetting, or forminga cell aggregatebetweenasingle target nucleatedcell andanumberof redblood cells (RBCs), is
a simple assay for cell adhesionmediatedby speciﬁc receptor-ligand interaction.For example, rosette formationbetweensheepRBC
and human lymphocytes has been used to differentiate T cells from B cells. Rosetting assay is commonly used to determine the
interaction of Fcg-receptors (FcgR)expressedon inﬂammatory cells and IgGcoatedonRBCs.Despite itswide use inmeasuring cell
adhesion, thebiophysical parameters of rosette formationhavenot beenwell characterized.Herewedevelopedaprobabilisticmodel
to describe the distribution of rosette sizes, which is Poissonian. The average rosette size is predicted to be proportional to the
apparent two-dimensionalbindingafﬁnityof the interacting receptor-ligandpair and their sitedensities. Themodelhasbeensupported
by experiments of rosettes mediated by four molecular interactions: FcgRIII interacting with IgG, T cell receptor and coreceptor CD8
interacting with antigen peptide presented by major histocompatibility molecule, P-selectin interacting with P-selectin glycoprotein
ligand 1 (PSGL-1), and L-selectin interactingwith PSGL-1. The latter two are structurally similar and are different from the former two.
Fitting the model to data enabled us to evaluate the apparent effective two-dimensional binding afﬁnity of the interacting molecular
pairs: 7.19 3 105 mm4 for FcgRIII-IgG interaction, 4.66 3 103 mm4 for P-selectin-PSGL-1 interaction, and 0.94 3 103 mm4 for
L-selectin-PSGL-1 interaction. These results elucidate the biophysical mechanism of rosette formation and enable it to become a
semiquantitative assay that relates the rosette size to the effective afﬁnity for receptor-ligand binding.
INTRODUCTION
Rosetting is an immunological assay for a receptor-
expressing target nucleated cell to form aggregates with
ligand-coated erythrocytes, or red blood cells (RBCs) (1,2).
In a typical rosetting procedure, cells are mixed at a ratio of
100 RBCs per target cell (1). After incubation, the cells are
inspected visually using a hemocytometer. A rosette is de-
ﬁned as a target cell bound with a given number (usually
three) or more of RBCs. The percentage, or fraction, of target
cells that form rosettes is reported as a metric for the extent of
adhesion mediated by the speciﬁc receptor-ligand interaction
in question. Before the advent of lymphocyte speciﬁc mono-
clonal antibodies (mAbs), rosetting was used to fractionate
subpopulations of cells such as thymocytes and bone marrow
cells in the early 1970s (2). Many erythrocyte species, in-
cluding sheep and human, were tested for their ability to
form rosettes with T cells. Rosetting with sheep RBCs has
been used to differentiate human T lymphocytes from B
lymphocytes, because T cells, but not B cells, express re-
ceptor CD2, which binds counter-receptor CD58 that is ex-
pressed on sheep RBCs (1,2). Human RBCs form rosettes
with activated T cells but not with naı¨ve T cells, because
CD58 is expressed on human RBCs at a lower level than on
sheep RBCs and CD2 expression is low on naı¨ve T cells but
is upregulated by activation (1,3).
Because of its dependence on the speciﬁc interactions of
receptors and ligands and on their expression levels,
rosetting has been used as a simple assay for receptor-
mediated cell adhesion (1). Apart from classical adhesion
receptors, rosetting assay has also been widely used in mea-
suring the functional state of Fc g-receptors (FcgRs), be-
cause the adhesion of FcgRs-expressing inﬂammatory cells
to antibody-coated target cells is a prerequisite for initiation
of FcgR-mediated effector functions such as antibody-
dependent cellular cytotoxicity and phagocytosis (4,5). How-
ever, rosetting has not been regarded as a quantitative method
in spite of these routine uses by immunologists for functional
assays. The reason is that the measured rosette fraction has not
been quantitatively related to the molecular properties of the
interacting receptors and ligands.
Thus, a mathematical model that describes rosette forma-
tion in terms of themolecular properties can turn rosetting into
a more quantitative assay. This model has to account for the
observation that rosetting is nondeterministic, as it always
results in a mixed population of target cells bound with
variable numbers ofRBCs, or variable rosette sizes, that range
from none to 10 some RBCs per target cell. To introduce
randomness in themathematical description for the size of any
particular rosette, an early model assumed heterogeneity in
the binding afﬁnity of the interacting receptors and ligands
(6). The same assumption was used in a later model (7). This
assumption does not seem valid, as receptor-ligand binding
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afﬁnity is an intrinsic property of the interacting molecular
pair, and as such, should not vary from cell to cell in a pop-
ulation. Neither model has been tested experimentally.
More recently, we have developed a series of mathemat-
ical models for treatment of adhesion mediated by a low
number of receptor-ligand bonds (8–12). A key feature of
this type of adhesions is their weakness, such that whether
adhesion occurs becomes random, thereby requiring a pro-
bability to describe the likelihood of its occurrence. We
solved the probability of adhesion in terms of the densities of
the receptors and ligands as well as their binding afﬁnity (8–
12). Here, we extended this approach to model the rosetting
assay, which results in a Poisson distribution for rosette
sizes. Experimental tests of the mathematical model were
performed using RBCs coated with multiple densities of
IgG- or selectin rosetting, respectively, with nucleated cells
expressing multiple levels of FcgRIII (CD16) or selectin
ligand. Rosette formation was shown to be initiated by low
number of weak IgG-FcgR or selectin-ligand bonds, fol-
lowed by a stabilizing step that enables the rosettes to survive
the lengthy handling process. Apparent binding afﬁnities
were evaluated from ﬁtting the Poisson distributions to the
measured rosette size histograms or the rosetting fractions.
These provided strong support for the validity of our model.
MODEL DEVELOPMENT
The starting point of our mathematical model is the prob-
ability of adhesion, Pa, which is a measure of the likelihood
for a receptor-expressing cell to adhere to a ligand-expressing
cell when the two are put into contact. For static experiments
conducted in the absence of dislodging forces such as the
rosetting assay, we have previously shown (8,9) that the
probability of no adhesion, 1 Pa, decays exponentially with
increasing densities of the receptors (mr) and ligands (ml) as
well as their binding afﬁnity (Ka), such that
Pa ¼ 1 expðmrmlAcKaÞ; (1a)
where Ac is the contact area. An implicit simplifying as-
sumption for Eq. 1a is that the adhesion is mediated by a
single species of receptor-ligand pair and their binding is a
single-step second-order forward and ﬁrst-order reverse
reaction. More involved kinetic mechanisms can be similarly
modeled, including multi-valent, multi-species, and multi-
step binding as well as the combinations thereof. For
example, the adhesion probability for a single-step reversible
reaction of nr receptors binding to nl ligands to form nb bonds
can be expressed by (9)
Pa ¼ 1 +
N
m¼0
ðmnrr mnll Anbc KaÞm=ðm!Þnb
 1
: (1b)
The adhesion probability for the concurrent but independent
binding of two distinct receptor species (of respective surface
densities mr1 and mr2) to their corresponding ligands (of re-
spective surface densitiesml1 andml2) can be expressed by (11)
Pa ¼ 1 expðmr1ml1AcKa1  mr2ml2AcKa2Þ; (1c)
where Kai (i ¼ 1, 2) are the respective binding afﬁnities for
the two species. The adhesion probability for a two-step
reaction consisting of a second-order forward and ﬁrst-order
reverse process in the ﬁrst step and a ﬁrst-order forward and
ﬁrst-order reverse process in the second-step can be ex-
pressed by (see Appendix)
Pa ¼ 1 exp½mrmlAcKa1ð11Ka2Þ: (1d)
Here Kai are the respective binding afﬁnities for the two
steps. Setting nr¼ nl ¼ nb ¼ 1 in Eq. 1b, mr2 ¼ 0, ml2 ¼ 0 or
Ka2 ¼ 0 in Eq. 1c, and Ka2 ¼ 0 in Eq. 1d reduce Eq. 1b–d, to
Eq. 1a, as expected.
For cells in suspension, it is reasonable to assume uniform
distributions of receptors and ligands on their surfaces. Our
previous experiments (9,13–17) suggest that binding of a
ligand-coated RBC to one region of the receptor expressing
target cell surface does not affect the ability of another RBC
to adhere to another surface region on the same target cell, as
long as the two RBCs do not sterically hinder one another,
since the ligands on the two RBCs do not compete for the
same subpopulation of receptors on the target cell. Since the
RBCs greatly outnumber the target cells during mixing, each
target cell should have equal opportunity to make contact
with as many RBCs as allowable by the geometric constraint.
Let N be the maximum number of RBCs that are geomet-
rically possible to simultaneously contact with a target nu-
cleated cell (N ; 12–30, depending on the size of the target
cell relative to that of the RBC) (1). Each of these N contacts
should be independent and have an equal probability Pa to
adhere and an equal probability 1 – Pa not to adhere. The
probability of having n (n ¼ 0, 1, . . ., N) RBCs to sim-
ultaneously adhere to a target cell (called the size of a rosette)
therefore obeys a binomial distribution:
pn ¼ Nn
 
P
n
að1 PaÞNn: (2)
The mean rosette size Ænæ can be calculated from Eq. 2, Ænæ¼
PaN. If Ænæ/N  1, Eq. 1 can be linearized
Pa ¼
mrmlAcKa for monovalent; single-species; single-step
m
nr
r m
nl
l A
nb
c Ka for multi-valent; single-species; single-step
mr1ml1AcKa11mr2ml2AcKa2 for monovalent; dual-species; single-step
mrmlAcKa1ð11Ka2Þ for monovalent; single-species; two-step
8><
>>:
(3)
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The binomial distribution can be approximated by the
Poisson distribution:
pn ¼ ðPaNÞ
n
n!
expðPaNÞ: (4)
This equation describes the size distribution of rosettes in a
population.
Results of a rosetting experiment are usually expressed in
terms of the rosette fraction, deﬁned as the percentage of
rosettes exceeding a certain size,
Pðn $ ncÞ ¼ +
N
n¼nc
pn ¼ 1 +
nc1
n¼1
ðPaNÞn
n!
expðPaNÞ; (5)
where nc is a predetermined rosette size, e.g., nc ¼ 3. Pa
in Eqs. 4 and 5 are given by Eq. 3 or by other expressions
appropriate for the kinetic mechanisms in question.
MATERIALS AND METHODS
Cells, antibodies, and proteins
Chinese hamster ovary (CHO) cells transfected to express the NA2 allele of
human FcgRIIIb (CD16bNA2) were cultured in the same media as reported in
our previous work (4). The expression of CD16bNA2 was periodically
checked via ﬂow cytometry (FACSCalibur, BD Biosciences, San Jose, CA).
Human promyelocytic leukemia (HL-60) cells from ATCC (Rockville, MD)
were grown in complete RPMI 1640 media supplemented with 2 mM
L-glutamine, 100 U/ml penicillin, 10 mg/ml streptomycin, and 10% fetal
bovine serum. HL-60 cells constitutively express P-selectin glycoprotein
ligand 1 (PSGL-1), which binds both P- and L-selectin.
Erythrocytes were isolated from whole blood of normal healthy vol-
unteers as previously described (13). Brieﬂy, ;7 ml whole blood was col-
lected by venipuncture into sterile Vacutainers (BD Biosciences) containing
EDTA. This was carefully layered over 3 ml of Histopaque 1119 and
centrifuged (30 min, 700 3 g, room temperature). The supernatant was
removed and the pelleted erythrocytes were washed once in RBC storage
solution (EAS45) (18). RBCs were stored aseptically at 4C in EAS45, at
;20% hematocrit for up to 3 weeks with negligible hemolysis.
Naı¨ve F5 T cells were puriﬁed from spleens of F5 T cell receptor (TCR)
transgenic mouse using a mouse CD81 T cell enrichment column (R&D
Systems, Minneapolis, MN) and stored in complete RPMI media supple-
mented with 100 U/ml interleukin-2 at 37C for up to 3 d.
Anti-CD16 mAb CLBFcgran-1 (mouse immunoglobulin 2a, mIgG2a)
(19) and anti-CD58 mAb TS2/9 (mIgG1) (1) have previously been de-
scribed. Human IgG (hIgG) and mIgG1, FITC-conjugated goat anti-hIgG
antibody, FITC-conjugated goat anti-mouse antibody, as well as bovine
serum albumin (BSA) were purchased from Sigma Chemical (St. Louis,
MO). hIgG serves as a low afﬁnity ligand for CD16bNA2.
Soluble P-selectin construct consisting of the Lec-EGF domains and nine
consensus repeats (20), anti-P-selectin blocking (G1) and capturing (S12)
mAbs (both mIgG1) (21), as well as anti-PSGL-1 blocking mAb PL1
(mIgG1) (22) have been described previously. Soluble L-selectin construct
consisting of the Lec-EGF domains and two consensus repeats (23), and
anti-L-selectin blocking mAb DREG56 (24) and capturing mAb CA21 (23)
(both mIgG1) were generous gifts from Dr. T. K. Kishimoto (Millennium
Pharmaceuticals, Boston, MA). Monomeric botinylated major histocompat-
ibility (MHC) molecules (H-2Db allele) with a single biotin at the C-terminus
were produced by the National Institutes of Health (NIH) Tetramer Facility
at Emory University. The MHC molecules were complexed with an agonist
peptide (pMHC) from the inﬂuenza virus recognized by the F5 TCR (25).
Coupling proteins onto RBCs
A previously described, modiﬁed chromium chloride method was used to
couple hIgG or capturing mAbs (S12 or CA21) onto the surface of fresh
human RBCs (17,26). Coupling efﬁciency of proteins was examined by ﬂow
cytometry, using CD58 that is constitutively expressed on RBCs at a known
density as a standard (1). hIgG-coated RBCs were directly used in rosetting
experiments with CD16bNA2-transfected CHO cells, whereas capturing
mAb-coated RBCs were ﬁrst incubated with 50–200 ng/ml of respective
selectin constructs for 30 min at 4C before used in rosetting experiments
with HL-60 cells.
A biotin-streptavidin coupling method was used to coat the biotinylated
pMHC monomers onto the surface of human RBCs. After washing with
phosphate-buffered saline (PBS), human RBCs were incubated with Biotin-
X-NHS (Calbiochem, San Diego, CA) for 30 min at room temperature
according to the manufacturer’s instruction. RBCs were washed ﬁve times
using PBS containing 2 mg/ml BSA. Next, streptavidin (Sigma) was added
to the RBCs at a concentration of 0.5 mg/ml. After 30 min incubation, cells
were washed to remove nonbound streptavidin. The biotinylated pMHC
monomers were then added to RBC for 1 h incubation at room temperature.
After washing three times in PBS, the RBCs were directly used in rosetting
experiment with naı¨ve T cells and can be stored in EAS45 for several weeks.
Site density determination
Site densities of surface proteins coated on RBCs or expressed on CHO or
HL-60 cells were measured using ﬂow cytometry and/or immunoradiometric
assay (IRMA). To measure densities of hIgG coated via CrCl3 coupling,
RBCs were incubated directly with FITC-conjugated goat anti-hIgG
antibody (4.7 equivalent FITC per IgG) at a concentration of 10 mg/ml in
200 ml of FACS buffer (RPMI/5 mM EDTA/1% BSA/0.02% sodium azide)
on ice for 40 min. To measure the CD16bNA2 or PSGL-1 expression, CHO
or HL-60 cells were incubated ﬁrst with anti-CD16 mAb CLBFcgran-1 or
anti-PSGL-1 mAb PL1, and then with FITC-conjugated goat anti-mouse
secondary antibody (4.4 equivalent FITC per IgG). After washing, the cells
were analyzed by ﬂow cytometry (Fig. 1 a, inset). The site densities were
then calculated by comparing the ﬂuorescence intensities of the cells with
those of standard beads (Bangs Labs, Fishers, IN) (9,17) (Fig. 1 a). To
measure densities of P- or L-selectin coupled by capturing mAb-coated
RBCs, one set of RBCs precoated with a range of densities of the relevant
capturing mAb (ﬁve densities for each selectin) were incubated with FITC-
conjugated goat anti-mouse antibody and the ﬂuorescence intensities were
measured using ﬂow cytometry as above. Another set of RBCs precoated
with the same range of densities of capturing mAb were incubated with the
corresponding selectin and their site densities were measured by IRMA
(17,20). A calibration curve was obtained for each selectin by plotting the
selectin site density against the mean ﬂuorescence intensity of the capturing
mAb (Fig. 1 b), thereby allowing calculation of the site densities of the
selectins from the mean ﬂuorescence intensities of the capturing mAb.
Rosetting assay
A modiﬁed rosetting procedure, described in detail previously (1,3), was
used in the study presented here. Typically, rosetting requires two types of
cells, one of larger size but smaller number and the other of smaller size but
larger number. Usually the former (termed target cells) are nucleated cells
expressing the receptors, and the latter are RBCs expressing the counter-
receptor (or ligands). Here we used several cellular and molecular systems,
all of which have previously been described (4,17,25). The ﬁrst system
consisted of transfected CHO cells expressing CD16bNA2 rosetting with
human RBC coated with hIgG (via CrCl3 coupling). The second system
consisted of HL-60 cells expressing PSGL-1 rosetting with RBC coated with
recombinant P-selectin or L-selectin constructs coupled by the respective
capture mAbs. The third system was composed of naı¨ve F5 T cells
expressing TCR and CD8 rosetting with RBC coated with recombinant
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pMHC constructs. Cells were washed with RPMI 1640 plus 5% IgG-free
serum, mixed at a ratio of 100 RBCs per target cell in total volume of 200 ml,
centrifuged at 500 rpm for 5 min or sedimented under gravity without
centrifugation (CHO or HL-60 cells) or centrifuged at 1000 rpm for 1 min
(T cells), and incubated on ice over 2 h or at room temperature for indicated
time. The cell pellet was gently resuspended with 10–15 times of pipetting,
and the rosettes so formed were visualized under a light microscope or
a scanning electron microscope (Fig. 2, a and b). More than 300 target CHO
or HL-60 cells or 100 T cells were counted within 10 min for each condition
in each run of rosetting assay to ensure stable distribution of rosette sizes.
All assays were performed in at least duplicate.
Data analysis
To test our model, a Poisson distribution (Eq. 4) was ﬁtted to histograms of
measured rosette sizes to evaluate the mean rosette size, Ænæ ¼ PaN. The
expression for Pa depends on the kinetic mechanism, four of which have
been given by Eq. 3. To test the validity of the multi-valent, single-species,
and single-step binding model, Ænæ was plotted against the receptor and
ligand densities to evaluate nr and nl. The lumped binding afﬁnity, AcKaN
(if both mr and ml were known and nb ¼ 1), or AcmlKaN (if mr was known
and nl ¼ 1), was calculated.
RESULTS
Rosette assay is insensitive to handling
procedure after stabilization
Rosette formation was quantiﬁed by size distribution of
rosettes, pn, as a function of n. A size n rosette is deﬁned as
an aggregate of n RBCs adhering simultaneously to a single
target cell but not among themselves (Fig. 2, a and b). For
rosette formation to be used as a quantitative assay, it is
necessary that the measurements be robust and not signif-
icantly affected by a modest variation in the handling
procedure, as forces applied to the rosettes during handling
are difﬁcult to control and inevitably variable from time to
time and from experimenter to experimenter. Very similar
rosette size distributions were obtained when the incubation
time to allow RBCs to rosette with HL-60 cells was varied
between 2 and 6 h and when the number pipetting to
resuspend the RBC-CHO rosettes was varied between 5 and
FIGURE 1 Site density determination. (a). Flow cytometry was used to
determine site density of hIgG coated on RBCs. Calibration curve of
standard beads was plotted as molecules of equivalent soluble ﬂuoro-
chromes (MESF) against ﬂuorescence intensity of beads measured by
cytometry (inset, solid histograms labeled Beads) using manufacturer-
provided program. Fluorescence intensity of coated-hIgG was measured
from the cytometry (inset, open histogram labeled hIgG) and the site density
was estimated from calibration curve of standard beads after subtracting
negative control (inset, open histogram labeled NC). (b) Combined
immunoradiometric and ﬂow cytometry assays were employed to determine
site densities of selectins captured by mAbs precoated on RBCs. Calibration
curve was plotted as site density of P- or L-selectin, determined using an
IRMA, against ﬂuorescence intensity of capture mAbs (S12 or CA21),
measured using ﬂow cytometry assay. Data for P- (open circles) and
L-selectin (open squares) were respectively ﬁtted with straight lines (solid
lines).
FIGURE 2 Photomicrographs of light microscopic image (a) and scan-
ning electron microscopic image (b) of a HL-60 cell rosetting with human
red blood cells.
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30 times (Fig. 3, a and b). In addition, consistent rosette size
distributions were obtained by three different experimenters
(data not shown). These data indicate that the measured
rosette size distributions are objective and reliable.
Two more experiments were performed to test the stability
of rosette formation over incubation period and during mixing
and handling. In the ﬁrst experiment, HL-60 cells were
mixed with P-selectin-coated RBCs. One sample was imme-
diately transferred to a hemocytometer for observation,
whereas another sample was centrifuged, incubated, and
resuspended, then transferred to the hemocytometer for
observation as in the rosetting assay. The latter sample
resulted in a mean rosette size of Ænæ¼ 0.13 for P-selectin site
density of mr ¼ 0.7 mm2, consistent with the results
summarized in Table 1 obtained using more extensive data
(see below). In sharp contrast, essentially no rosettes were
observed in the former sample, which was comparable to the
nonspeciﬁc control. In the second experiment, rosettes
formed in the ﬁrst experiment (from the second sample)
were transferred to a micropipette system for direct exam-
ination of the adhesion strength between the HL-60 cell and
the RBC(s). Rosettes with some of the RBCs stuck to the
cover glass were identiﬁed, and the HL-60 cells in those
rosettes were aspirated by a micropipette, which was then
retracted to pull the HL-60 cells away from the RBCs. It was
found that the HL-60 cells adhered strongly to the RBCs. In
some cases, instead of separating the cells, the pipette
retraction actually resulted in membrane tethers extrusion
from the cells.
Binding is mediated by speciﬁc
receptor-ligand interactions
Binding was quantiﬁed by the mean rosette size, Ænæ, which
was estimated by ﬁtting the Poisson distribution (Eq. 4) to
the histograms of measured rosette sizes (see Figs. 5 and 6).
Rosettes were formed between CD16bNA2-transfected CHO
cells and RBCs when the RBCs were coated with hIgG, but
was abolished when hIgG ligand was replaced by an
irrelevant protein BSA (Fig. 4 a). Rosettes were also formed
between HL-60 cells and RBCs when the RBCs were coated
with appropriate capturing mAbs (S12 or CA21) and
incubated with the corresponding soluble P- or L-selectin
constructs, but were abrogated when the capturing mAbs
were replaced with the isotype-matched irrelevant mIgG1.
In addition, rosette formation was blocked by mAbs against
P-selectin (G1) and L-selectin (DREG56) (Fig. 4 b). These
data demonstrated that the observed rosette formation was
mediated by the speciﬁc interactions between the CD16bNA2-
hIgG or selectin-PSGL-1 molecules.
FIGURE 3 Insensitivity of rosette distribution to handling procedure.
Rosette size distributions were measured (a) when incubation time to allow
L-selectin-coated RBCs to rosette with PSGL-1-expressing HL-60 cells was
varied from t¼ 2 (open bars), 3.5 (solid bars), to 6 (hatched bars) hr and (b)
when the number of pipetting to resuspend the rosettes between CD16bNA2-
transfected CHO cells and hIgG-coated RBCs was changed from N ¼ 5
(open bars), 10 (solid bars), 15 (rightward-hatched bars), 20 (leftward-
hatched bars), to 30 (dotted bars) times. Data are presented as the mean 6
SD of fraction of rosette sizes in at least duplicate.
TABLE 1 Summary mean rosette size and 2D apparent
afﬁnity values
Molecular
systems
mr
(mm2)
ml
(mm2) Ænæ
AcKaN
3 105 (mm4)
CD16bNA2-hIgG 1023 20.3 1.65 6 0.13 7.95 6 0.63
1023 10.3 0.59 6 0.03 5.63 6 0.30
1023 6.6 0.25 6 0.06 3.68 6 0.87
115 11.9 0.12 6 0.01 9.66 6 2.94
Mean average 6.73 6 2.62
Molecular
systems
mr
(mm2)
ml
(mm2) Ænæ
AcKaN
3 103 (mm4)
P-selectin-PSGL-1 3.4 21.3 0.23 6 0.01 3.18 6 0.11
1.9 21.3 0.25 6 0.01 6.12 6 0.17
2.2 21.3 0.22 6 0.01 4.67 6 0.29
Mean average 4.66 6 1.47
L-selectin-PSGL-1 10.0 21.3 0.25 6 0.02 1.16 6 0.10
11.7 21.3 0.10 6 0.00 0.40 6 0.02
4.5 21.3 0.12 6 0.01 1.26 6 0.05
Mean average 0.94 6 0.47
The mean rosette size Ænæ was determined by ﬁtting the Poisson distribution
(Eq. 4) to the measured rosette histograms (Figs. 5 and 6). The effective 2D
apparent afﬁnity multiplied by N (12) (1) was calculated from AcKaN ¼
Ænæ/(mr 3 ml).
Data are presented as mean 6 S.D.
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Rosette size varies randomly and follows
a Poisson distribution
Ligand-coated RBCs were allowed to rosette with receptor-
expressing target (CHO or HL-60) cells. The sizes of the
rosettes (i.e., number of RBCs per target cell) were visualized
microscopically, which were then analyzed by histograms
(Figs. 5 and 6, bars). The random occurrence and variable
rosette sizes might result from the heterogeneity of the cells
and their expression of the interacting molecules or from the
inherent stochastic nature of weak adhesion mediated by small
number of bonds. Multiple lines of evidence support the latter
cause, i.e., weak and stochastic adhesion as the mechanism for
the random rosette size. Increasing the site densities of
receptors and ligands reduced the randomness and increased
the size of the rosettes. Conversely, as the receptor and/or
ligand site densities decreased, the histogram shifted leftward
toward smaller rosette sizes (Fig. 5, a–d). Small rosette sizes
(most frequently no more than two RBCs per target cell)
imply low adhesion probabilities because Pa ¼ Ænæ/N. Indeed,
direct calculation found Ænæ ; 0.12–1.87, which were small
compared to the maximally allowable rosette size N ( 12).
Low adhesion probabilities can result from low densities of
interacting molecules by virtue of the mass action effect, as
expected from Eq. 1. In fact, the site densities used in the
rosetting experiments are comparable to those used in our
previous micropipette experiments performed using the same
cellular and molecular systems, which resulted in similarly
low adhesion probabilities (9,13–15,17). These arguments also
justify the approximation used in Eq. 3.
An important prediction of the stochastic adhesion hy-
pothesis is the Poisson distribution of the rosette sizes. It is
evident that, for all four pairs of CD16bNA2-IgG site den-
sities studied, the measured rosette size histograms (bars)
were in excellent agreement with the Poisson distributions
(curves) obtained by using single-parameter ﬁts (R2 ¼ 0.93
; 1.00) (Fig. 5, a–d) and the ﬁtted mean rosette sizes also
agreed very well with the directly calculated Ænæ values,
which were quite small (0.12 ; 1.65).
Additional tests were done using RBC-HL-60 cell
rosettes mediated by P- or L-selectin interacting with
PSGL-1, two molecular systems that are similar to each
other structurally and functionally but very different from
the CD16bNA2-IgG system. Since the variations in site
densities were modest (mr ¼ 3.4, 1.9, and 2.2 mm2 for
P-selectin, and mr ¼ 10, 12, and 4.5 mm2 for L-selectin),
rosettes measured using three densities for each selectin
were pooled together for histogram analysis of their size
distributions, which were then ﬁtted by Eq. 4. Again,
Poisson distributions (curves) ﬁt the data (bars) very well
(Fig. 6, R2  1.00) and the ﬁtted mean rosette sizes were
also in excellent agreement with the directly calculated small
Ænæ values (0.10 ; 0.35).
FIGURE 4 Binding speciﬁcity. (a) CD16bNA2-expressing CHO cells
rosetted with hIgG-coated RBCs (solid bar). The rosettes were completely
abolished by replacing hIgG with BSA (open bar). (b) Ligand-expressing
HL-60 cells respectively rosetted with P- or L-selectin-coated RBCs (solid
bars). The rosetting was signiﬁcantly reduced by replacing the capture
mAbs with isotype-matched irrelevant mIgG1 (open bars) or by incubating
with blocking mAbs (hatched bars). Data were presented as the mean6 SE
of mean rosette size Ænæ.
FIGURE 5 Comparison of measured and ﬁtted size distributions of CHO-
RBC rosettes mediated by CD16bNA2-hIgG interactions at the site densities
of mr3 ml ¼ 10233 20.3 (a), 10233 10.3 (b), 10233 6.6 (c), and 1153
11.9 (d) mm4. Total of .300 CHO cells were counted in each experiment
and the measurements were repeated in at least duplicate at each site density.
The histograms of rosette sizes (pn corresponds to the probability of a CHO
cell bound with n RBCs, hatched bars) were presented as mean6 SD of$2
experiments of$300 rosette counts for each site density, which was ﬁtted by
a Poisson distribution (Eq. 4; curves).
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Dependence of mean rosette size on site densities
of receptors and ligands
The kinetic mechanism of an interaction between receptors
and ligands can be determined by examining the dependence
of adhesion on their site densities, where the site densities
were adjusted to avoid the conditions that result in area
contact (as opposed to point attachments) mediated by a
large number of molecular interactions. To do that we plotted
the log of the mean size of rosettes mediated by CD16bNA2-
IgG interaction against the log of the site densities of
receptors (Fig. 7 a, bottom abscissa) and ligands (Fig. 7 a,
top abscissa). For multi-valent, single-species, and single-
step binding, Ænæ ¼ mnrr mnll Anbc KaN from Eqs. 3 and 4. The
slopes of the linear ﬁts to the data in Fig. 7 a represent the
stoichiometric coefﬁcients. The values so obtained are nr 
0.7 and nl  1.5, which predicts nr ¼ nl ¼ nb ¼ 1 as it is
required that the stoichiometric coefﬁcients are integers and
min(nr,nl) $ nb $ 1. These results conﬁrm the previously
determined second-order forward, ﬁrst-order reverse kinetic
mechanism for CD16-IgG interactions (9, 13–15) and
provide additional support of our model.
The conclusion regarding the CD16-IgG kinetic mecha-
nism is further supported by the linear appearance of the Ænæ
vs. mr3 ml plot (Fig. 7 b), since Ænæ ¼ (AcKaN)3 (mr3 ml)
from Eqs. 3 and 4 based on the determined stoichiometry.
The mean rosette sizes in Fig. 7 b were determined using two
methods: a), directly calculated from all individually mea-
sured rosettes, and b), evaluated by ﬁtting Poisson distribu-
tions to the rosette size histograms. The agreement between
four sets of values determined by the two methods provides
further support of our model (Fig. 7 b).
Measuring binding afﬁnity from a quantitative
rosette assay
It follows from Ænæ ¼ (AcKaN) 3 (mr 3 ml) that the slope of
the linear ﬁt to the data in Fig. 7 b is equal to the effective
two-dimensional (2D) binding afﬁnity, AcKa, multiplied by
the maximally allowable rosette size, N. The effective 2D
binding afﬁnity (multiplied by N) can also be estimated from
the mean rosette size determined using a single pair of site
densities, i.e., AcKaN ¼ Ænæ/(mr 3 ml). Values of AcKaN so
determined are summarized in Table 1. As can be seen,
consistent values were obtained for the four CD16bNA2-IgG
FIGURE 6 Comparison of measured and ﬁtted size distributions of HL-
60-RBC rosettes mediated by (a) P-selectin-PSGL-1 interactions or (b)
L-selectin-PSGL-1 interactions. Total of.300 HL-60 cells were counted in
each experiment and the measurements were repeated in at least duplicate at
each site density. Rosette size histograms (pn corresponds to the probability
of a HL-60 cell bound with n RBCs, hatched bars) at three site densities
for each selectin were lumped together and presented as mean 6 SD of
$10 experiments of $300 rosette counts for each selectin, which was ﬁtted
by a Poisson distribution (Eq. 4; curves).
FIGURE 7 Dependence of mean rosette size and independence of
apparent binding afﬁnity on site density for CHO-RBC rosettes mediated
by CD16bNA2-hIgG interactions. (a) The log of mean rosette size directly
measured (squares) and calculated by ﬁtting a Poisson distribution to the
rosette size histogram (circles) was plotted against the log of receptor
(bottom abscissa) and ligand (top abscissa) densities, which were ﬁtted with
straight lines (lines) to obtain the stoichiometric coefﬁcients. (b) Mean6 SE
of rosette size directly measured (squares) and calculated by ﬁtting a Poisson
distribution to the rosette size histogram (circles) was plotted against the
product of the densities of receptors and ligands and then ﬁtted by a straight
line (dotted line). The slope represents the apparent binding afﬁnity
(multiplied by the maximally allowable rosette size N), AcKaN ¼ 7.19 3
105 mm4.
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densities. The average AcKaN value (6.73 3 10
5 mm4) is in
good agreement with the slope of the linear ﬁt (7.19 3 105
mm4) obtained from Fig. 7 b. The ranges of site density
variations were too small for P- and L-selectin to produce
sufﬁciently large ranges of mean rosette size variations to
allow for robust linear plots. Therefore, the effective 2D
binding afﬁnities (multiplied by N) were determined for each
site density and the average values were reported in Table 1.
Results of a rosetting assay are commonly reported as
rosette fraction, deﬁned as the percentage of target cells that
have formed rosettes with RBCs. A rosette is deﬁned as
having no less than a predetermined number (nc) of RBCs
bound to a target cell. Effective 2D binding afﬁnity (mul-
tiplied by N) can be calculated from the measured rosette
fraction using the unity stoichiometric coefﬁcient version of
Eqs. 3 and 5. Fig. 8 shows the AcKaN values so obtained for
the three cellular and molecular systems studied. As can be
seen, consistent AcKaN values calculated from four different
choices of nc (1, 2, 3, and 4) were obtained for the CD16b
NA2-
IgG system, which are also in excellent agreement with that
obtained previously from ﬁtting the Poisson distributions to the
rosette size distributions (Fig. 8 a), supporting the reliability of
estimated binding afﬁnity of CD16bNA2-hIgG interactions.
Although greater variations in the estimated AcKaN values
were seen for the selectin systems (Fig. 8 b), the results are still
deemed acceptable because these can be explained by
measurement errors (see Discussion below). Taken together,
these results provide strong support for our mathematical
model (Eqs. 4 and 5) and have demonstrated that 2D binding
afﬁnity can be evaluated from the rosetting assay.
DISCUSSION
Rosette formation is mediated by speciﬁc molecular inter-
actions. However, how the receptors and ligands regulate the
rosette size distribution through their expression and binding
afﬁnity was not quantitatively understood. The goal of the
present study was to obtain a quantitative understanding as
well as to develop and validate a model that captures such
understanding mathematically. The model is based on the
probability of adhesion, which was solved from the prob-
abilistic formulation for small system kinetics ﬁrst proposed
by McQuarrie (27). This theory has been developed into a
widely applicable framework for mathematical treatment of
various cell adhesion experiments including centrifugal
detachment (8,28), micropipette adhesion frequency assay
(9,13–15,17,29–31), and doublet formation and breakage
under ﬂow (10). Here, the theoretical framework has been
further extended to describe the rosetting assay. In all cases,
the kinetic rates and binding afﬁnity of the speciﬁc molecular
interactions are the determining parameters of the cell
adhesion functions. In the deterministic kinetic framework,
the binding afﬁnity determines how many bonds are formed.
By comparison, in the present probabilistic kinetic frame-
work, it determines how likely one molecule binds to an-
other. Regardless of the molecular site densities, the Poisson
distributions ﬁt the rosetting size histograms well (Figs. 5
and 6). Good agreement was found among binding afﬁnities
estimated from experiments using different molecular den-
sities for any of the three interacting molecular pairs studied
(Table 1). These results have supported the validity of the
model.
The applicability of our model depends on the validity of
the assumption that each RBC has equal opportunity to adhere
to the same target cell before being sterically hindered by the
geometric constraint. To allow easy observation and to in-
crease the sensitivity of the assay, the site densities were
adjusted to yield modest mean rosette sizes as shown in Figs.
2–6, which also satisﬁes the above assumption. High site
densities would produce area attachments (as opposed to point
attachments) mediated by a large number of molecular
interactions and yield large mean rosette sizes. This might
be the case in some published studies where the target cells
were completed surrounded by RBCs, which likely invali-
dates the above assumption. Such a case is exempliﬁed in Fig.
9 a, where the size distribution of pMHC-coated RBCs
rosetting with F5 T cells has a large fraction (.30%) of
rosettes having .6 RBCs. It is evident that the measured
rosette size distribution (solid bars in Fig. 9 a) no longer
follows the Poisson distribution (open bars in Fig. 9 a),
probably because the effect of steric interactions among ad-
hering RBCs became signiﬁcant in the large-sized rosettes.
Interestingly, after excluding the fractions of rosettes having 0
and .6 RBCs, the renormalized distribution (solid bars in
Fig. 9 b) becomes Poissonian again (open bars in Fig. 9 b).
These data clearly demonstrate how the absence or presence
of steric interactions determines whether or not the rosette size
follows a Poisson distribution even in different subpopula-
tions of cells assayed in the same experiment. From this
comparison, we conclude that steric interactions among
FIGURE 8 Estimation of apparent binding afﬁnity from measurements of
CHO-RBC rosettes mediated by CD16bNA2-hIgG interactions at mr 3 ml ¼
10233 20.3mm4 (a) and of HL-60-RBC rosettes mediated by P-selectin at
mr ¼ 3.4 mm2 or L-selectin at mr ¼ 10 mm2 interacting with PSGL-1 (b).
For each system, Eq. 5 was used to calculate the AcKaN value from the
measured rosette fraction for each of the following preset rosette size,
nc ¼ 1 (open bars), 2 (leftward-hatched bars), 3 (rightward-hatched bars),
or 4 (dotted bars). In addition, the AcKaN values were determined by
ﬁtting Poisson distributions (Eq. 4) to the rosette size distributions (solid
bars). Data are presented as the mean 6 SE.
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adhering RBCs had little adverse impact on the data shown
in Fig. 5 a, since a), the fraction of six or more adhering RBC
is very small (,2%), b), the rosette size distribution is
Poissonian, and c), the mean rosette size of Fig. 5 a correlates
with those in Fig. 5, b–d, by the law of mass action (Fig. 7).
The accuracy of the rosette size measurements is deter-
mined by several factors, including: a), subjectivity in judg-
ing whether a RBC is really attached or merely contiguous to
a target cell, b), objectivity of observing a three-dimensional
structure from a 2D projection and other observation errors,
and c), variation in the experimenter’s skill such as breaking
up some of the rosettes during resuspending cells before
counting. For example, miscounting one RBC in a size n
RBC rosette in an experiment that measured 300 target cells
would have introduced a 1/300 measurement error in the
rosette size fraction pn and a 11/300 measurement error in
the rosette size fraction pn1. These errors are trivial when pn
and pn1 are large, but become signiﬁcant when they are
small. This has been exempliﬁed in Fig. 10, where the
absolute values of relative errors, jDpn/pnj, between the ﬁtted
Poisson distributions and the measured rosetting size his-
tograms, increase with increasing n (Fig. 10 b) when n is
negatively correlated with pn (Fig. 5 b). When n is positively
correlated with pn (Fig. 5 a, the n ¼ 0 and 1 cases), however,
jDpn/pnj increase with decreasing n (Fig. 10 a, the n ¼ 0 and
1 cases). Similar results were found for other site densities of
the CD16bNA2-hIgG interaction mediated rosettes and for
selectin-PSGL-1 interaction mediated rosettes (data not
shown). The measurement errors also explain the variations
in the selectin-ligand binding afﬁnities estimated using in-
creasing nc (Fig. 8 b). Since n is negatively correlated with pn
in these cases (Fig. 6), the relative error in Pðn$ncÞ would
increase with increasing nc. The binding afﬁnity estimated
from the rosetting fraction Pðn$1Þ agrees best with that
estimated from ﬁtting the entire Poisson distribution because
p1, which has the smallest relative error, dominates the
ﬁtting. The accuracy of the effective 2D afﬁnity values is
further limited by that of the measurements of the site
densities of the receptors and ligands, which in general are
no better than 50%. This explains the fractional slope values
of the linear ﬁts to the data in Fig. 7 a.
The Poisson distribution of the rosette sizes suggests low
adhesion probabilities between the RBC and the target cell,
which implies a low number of receptor-ligand bonds.
However, this prediction is at odds with the fast kinetic rates
of these interactions and their ability to support stable rosette
formation over long time. The half-lives (reciprocal off-
rates) of bonds of P- and L-selectin interacting with PSGL-1,
of CD16bNA2 interacting with hIgG, and of F5 TCR
interacting with agonist pMHC have been measured using
single bond lifetime experiments (32,33) and/or the micro-
pipette adhesion frequency assay (13–17,34), which ranges
from a fraction of a second to a few seconds. How could
a few of these bonds with such short lifetimes support sta-
ble rosettes up to hours and be robust to variations in the
handling procedure (Fig. 3)? Although the underlying mech-
anisms are not clear, the ability of selectin-ligand and
FcgR-IgG interactions to mediate static binding has long
been observed (8,20,28,35). We hypothesize that the initial
FIGURE 9 Comparisons between the measured size distribution of
pMHC coated RBCs rosetting with T cells (solid bars) and the Poisson
distribution that matches the percentage of rosettes (nc $ 1) (open bars).
Data are presented as (a) a complete set and (b) a subset after exclusion of
the fractions of rosettes having 0 and .6 RBCs and renormalization.
FIGURE 10 The relative errors (absolute values) between measured and
ﬁtted rosette size fraction, j½pn(measured)  pn(ﬁtted)/pn(measured)j, were
plotted against the number of RBCs per target cell for CHO-RBC rosettes
mediated by CD16bNA2-hIgG interactions at two typical site densities,
mr 3 ml ¼ 1023 3 20.3 (a) and ¼ 1023 3 10.3 mm4 (b).
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interactions that mediated the rosette formation during cen-
trifugation or sedimentation when the RBCs contacted the
target cells were as weak and short-lived as those seen in the
micropipette adhesion frequency assay and single bond life-
time assay. However, during incubation, the rosettes were
stabilized, because by the time the cell pellet was resuspended,
the rosettes were quite stable, as the gentle pipetting that used
tips with wide opening would not disrupt them (Fig. 3). This
hypothesis was supported by two tests, which showed that
immediate re-suspension without incubation did not result in
countable rosettes.
The above hypothesis also explains the discrepancies
among the effective 2D afﬁnity values for the same selectin-
ligand interactions using different experimental methods.
The AcKa (¼ Ænæ/mrmlN) value for the P-selectin-PSGL-
1 interaction is 3.9 3 104 mm4 calculated from the Ænæ
value in Table 1, which is;30-fold smaller than the value of
1.2 3 102 mm4 previously estimated by the micropipette
adhesion frequency assay using the same HL-60 cells ex-
pressing 21.3 PSGL-1 per mm2 (17). A possible explanation
for the discrepancies may be that only a small fraction of the
initial weak bonds were able to be converted into strong
bonds or to recruit additional bonds, thereby giving rise to
much smaller apparent AcKa values. For example, the ef-
fective 2D afﬁnity for the P-selectin-PSGL-1 interaction
estimated from a long-term static sedimentation assay is 4.8
3 104 mm4, which agrees well with the value estimated in
this study but much smaller than the value measured by the
micropipette (17). As another support of this hypothesis, it
was previously noted that the mlAcKa value for E-selectin-
ligand interaction estimated from the long-term static cen-
trifugation experiment (8) is an order of magnitude smaller
than that estimated by the short-term micropipette adhesion
frequency assay (30).
However, an alternative hypothesis may be required to
explain the rosettes supported by the CD16bNA2-hIgG inter-
action. The effective 2D afﬁnity for this interaction calculated
from the Ænæ value in Table 1 is 5.6 3 106 mm4, which is an
order of magnitude larger than the 4.1 3 107 mm4 value
previously estimated by the micropipette adhesion frequency
assay (14). CD16 is a receptor capable of signaling for
immune effector function upon engagement of IgG Fc for
sufﬁciently long time, which may result in higher apparent
afﬁnity from a long-term assay than from a short-term assay.
Although elucidation of the stabilization process is be-
yond the scope of this study, possible mechanisms for ap-
parent changes in the binding characteristics over time may
include afﬁnity regulation, e.g., conformational changes that
result in higher afﬁnity and slower dissociation (35), avidity
regulation, e.g., receptor clustering that result in multimeric
bonds with higher avidity and slower dissociation (36), and
subsequent recruitment of additional interactions (37).
Although determining the mechanism(s) for stabilization
requires further studies, a multi-step binding model can be
proposed. For simplicity, we only consider two-step binding
(see Appendix), although multi-step binding can be similarly
modeled. In the case of afﬁnity regulation, the ﬁrst step
accounts for the initial low-afﬁnity (Ka1) binding, and the
second step gives rise to the high afﬁnity (Ka2) binding. The
avidity regulation case can also be treated as a two-step
process, with the ﬁrst step being the formation of a mono-
meric bond and the second step being the formation of a
dimeric bond. For the recruitment case, the ﬁrst step binding
triggers signaling, which results in subsequent recruitment of
additional adhesion molecules that bind in the second step.
The adhesion probability in the ﬁrst two cases is given by Eq.
1d and the overall propensity for binding is given by Ka1(11
Ka2). The only difference for the third case is that Ka2 in
Eq. 1d should be replaced by mr2ml2AcKa2 to account for the
mass action effect of the additional molecular species
recruited in the second step. The above discussion suggests
the following expression for the mean rosette size:
where h (0, h# 1) denotes the fraction of weak bonds that
undergoes stabilization.
This stabilization model is supported by three lines of
evidence. First, the observed rosettes require speciﬁc recep-
tor-ligand interaction as shown by the control experiments
(Fig. 4). Without the speciﬁc receptor-ligand binding (which
might occur only in the initial phase), stabilization could not
produce the Poisson distribution of rosette sizes. Second, the
afﬁnities evaluated from ﬁtting the rosette size distributions
with our model change when the interacting molecules are
changed, indicating their speciﬁcity. These data also rule out
the multi-species model (the adhesion probability of which is
given by Eq. 1c). More signiﬁcantly, they correlate with the
Ka’s of these interactions measured from separate experiments
(see above). Third, the Poisson distribution of the rosette size
shifts in response to the changes in the receptor and ligand
densities in a manner predicted by our model (Fig. 5). Since the
model has only a single parameter of mean rosette size, the Ænæ/
mrml value does not change with changingmr and ml (Fig. 7 b).
So this value must be proportional, although it may not be
equal, to the afﬁnity of the initial interaction Ka1. Equation 6
suggests an expression for the constant of proportionality,
which is Ac(11 Ka2)hN or Ac(11 mr2ml2AcKa2)hN depending
on the mechanism and fraction of stabilization.
Ænæ ¼ mrmlAcKa1ð11Ka2ÞhN for affinity or avidity upregulation
mr1ml1AcKa1ð11mr2ml2AcKa2ÞhN for subsequent recruitment ;

(6)
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The above discussion also reveals the limitation of using a
single binding constant to deﬁne the equilibrium between the
forward and reverse reaction of receptor-ligand interaction.
Indeed, the concept of binding afﬁnity is a useful but often
overly simpliﬁed model borrowed from the description of
chemical bonds at the atomic level. Although this concept
has successfully described many receptor-ligand binding
data obtained under given experimental conditions, compar-
ison between afﬁnities measured by different experiments
using different techniques over different timescales remains
a very challenging task. For this reason, the values estimated
from the rosette size distribution should be referred to as
‘‘apparent’’ effective 2D binding afﬁnities.
In conclusion, a probabilistic model for rosette formation
has been developed, which has enabled us to quantitatively
relate the rosette size distribution or rosette fraction to the
densities of receptors and ligands, their apparent binding
afﬁnity, the contact area, and the maximum rosette size. The
theoretical prediction compared well with the experimental
data for all the cellular and molecular systems examined. The
apparent binding afﬁnities so evaluated were consistent with
their values determined from other kinetic assays. The
insights obtained from this work may be applicable to quan-
titative understanding of other receptor-ligand interaction-
mediated cell-cell adhesion processes.
APPENDIX: STEADY-STATE SOLUTION TO A
TWO-STEP BINDING MODEL
Consider a two-step reaction of a receptor (R) binding to a ligand (L):
R1 L 
k1 1
k1
ðRLÞ1 
k1 2
k2
ðRLÞ2: (A1)
Here k11 (in mm
2s1) is the rate constant of the ﬁrst-step second-order
association process, and k1, k12, and k2 (all in s
1) are the respective rate
constants of the ﬁrst-step dissociation, second-step association, and second-
step dissociation processes, respectively, all of which are ﬁrst-order. Let
pn1 ;n2 be the probability for the system to be the state (n1,n2), i.e., having
n1 (RL)1 bonds and n2 (RL)2 bonds. Since bond formation and breakage
are assumed to be Markovian process, the rate of change of pn1 ;n2 in time t
depends only on the probabilities of the state (n1,n2) and its four intermediate
neighbors (n11,n2), (n111,n2), (n111,n21), and (n1-1,n211), which is
governed by the following master equations,
dpn1;n2
dt
¼ mrmlAck11pn11;n2 1 ðn11 1Þk1pn111;n2
1 ðn11 1Þk12pn11 1;n211 ðn21 1Þk2pn11;n211
 ½mrmlAck111 ðk11 k12Þn11 k2n2pn1 ;n2 ; (A2)
where Ac is contact area (in unit of mm
2). The kinetic rates are assumed
independent of n1 and n2 and the number of bonds is assumed to be much
smaller than the number of molecules in contact area. In the rosetting
experiments, the probabilities should have achieved the steady state, such
that the left-hand side of Eq. A2 becomes zero. In addition, the detailed
balance between (RL)1 bonds and (RL)2 bonds at equilibrium requires
ðn21 1Þk2pn1;n21 1 ¼ ðn11 1Þk1 2pn111;n2 : (A3)
Upon substitution of Eq. A3, the steady-state equation is simpliﬁed as
mrmlAck11pn11;n2 1 ðn11 1Þk1pn111;n2
 ðmrmlAck111 k1n1Þpn1 ;n2 ¼ 0: (A4)
The solution to Eq. A4 can be solved by mathematical induction. Assume
the general solution is of the form:
pn1 ;n2 ¼
ðmrmlAcKa1Þn1
n1!
ðmrmlAcKa1Ka2Þn2
n2!
3 exp½mrmlAcKa1ð11Ka2Þ; (A5)
where Kai ¼ k1i/ki (i ¼ 1, 2) is the binding afﬁnity of the ith step. It is
readily veriﬁable that this solution satisﬁes Eq. A3. Equation A5 is true for
the case of n1 ¼ n2 ¼ 0:
p0;0 ¼ exp½mrmlAcKa1ð11Ka2Þ; (A6)
because this expression has been chosen to allow Eq. A5 to satisfy the
normalization condition,+Nn1¼0;n2¼0pn1n2 ¼ 1. Since p1;n2 ¼ 0, setting n1 ¼
n2¼ 0 in Eq. A4 veriﬁes that Eq. A5 is true for the case of n1¼ 1 and n2¼ 0:
p1;0 ¼ mrmlAcKa1p0;0 ¼ mrmlAcKa1exp½mrmlAcKa1ð11Ka2Þ:
(A7)
Suppose Eq. A5 holds for n1 ¼ n and n1 ¼ n  1 (n. 1). Substituting these
assumed solutions for pn;n2 and pn1;n2 into Eq. A4 yields
pn11;n2 ¼
1
ðn11Þk1½ðmrmlAck111k1nÞpn;n2
mrmlAck11pn1;n2 
¼ ðmrmlAcKa1Þ
n11
ðn11Þ!
ðmrmlAcKa1Ka2Þn2
n2!
(A8)
3 exp½mrmlAcKa1ð11Ka2Þ:
Thus, Eq. A5 is shown to be true for n1 ¼ n1 1. Although Eq. A5 has only
been shown for the case of n2¼ 0 (Eqs. A6 and A7), the derivation of Eq. A8
does not require the speciﬁcation of n2. In addition, the solution for the
n2 . 0 case can be easily generated from that for the n2 ¼ 0 case using
Eq. A3. For example, setting n1 ¼ n2 ¼ 0 in Eq. A3 and using Eqs. A6 and
A7 result in
p0;1 ¼Ka2p1;0 ¼mrmlAcKa1Ka2exp½mrmlAcKa1ð11Ka2Þ;
(A9)
verifying that Eq. A5 is also true for the case of n1 ¼ 0 and n2 ¼ 1. It thus
follows from the principle of mathematical induction that Eq. A4 is true
for any nonnegative n1 and n2 values. The adhesion probability, Pa, can be
easily obtained from Eq. A6:
Pa ¼ 1p0;0 ¼ 1 exp½AcmrmlKa1ð11Ka2Þ: (A10)
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